Your browser doesn't support javascript.
loading
Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
Findlow, Jamie; Bayliss, Christopher D; Beernink, Peter T; Borrow, Ray; Liberator, Paul; Balmer, Paul.
  • Findlow J; Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Ltd, Tadworth, UK. Electronic address: Jamie.Findlow@pfizer.com.
  • Bayliss CD; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK. Electronic address: cdb12@leicester.ac.uk.
  • Beernink PT; Department of Pediatrics, School of Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: peter.beernink@ucsf.edu.
  • Borrow R; Public Health England, Manchester Royal Infirmary, Manchester, UK. Electronic address: ray.borrow@phe.gov.uk.
  • Liberator P; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Electronic address: Paul.Liberator@pfizer.com.
  • Balmer P; Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA. Electronic address: Paul.Balmer@pfizer.com.
Vaccine ; 38(49): 7716-7727, 2020 11 17.
Article en En | MEDLINE | ID: mdl-32878710

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Meningococicas / Neisseria meningitidis Serogrupo B / Infecciones Meningocócicas / Neisseria meningitidis Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Meningococicas / Neisseria meningitidis Serogrupo B / Infecciones Meningocócicas / Neisseria meningitidis Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article